Physician profile
Thomas David Willson
NPI 1043530819
$3,937.75
in general payments reported to CMS, 2019-2025
18 companies · $2,697 in 2025
The $2,697 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.72 · 2023: $328 · 2024: $863 · 2025: $2,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520 · Travel and Lodging: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.94 |
| Travel and Lodging | $1,368.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,672.17 | 2023-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Na, Delta |
| Abbvie INC. | $670.56 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Axogen | $232.03 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Integra Lifesciences Corporation | $220.49 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kls-Martin L.P. | $210.00 | 2024-2025 | |
| Sanara Medtech INC. | $144.46 | 2025 | Celleraterx |
| Solventum Corporation | $121.15 | 2025 | Prevena, V.A.C. Veraflo, V.A.C. Dermatac |
| Avita Medical Americas, LLC | $118.17 | 2025 | Recell |
| Musculoskeletal Transplant Foundation INC. | $113.16 | 2023-2024 | |
| Aesculap, INC. | $67.74 | 2025 | Aesculap |
| Urgo Medical North America, LLC | $59.80 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kerecis Limited | $58.94 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Allergan, INC. | $49.72 | 2022 | |
| Endo USA, INC. | $49.10 | 2024-2025 | Xiaflex |
| Elite Orthopedics, LLC | $46.26 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $41.21 | 2024 | Ovitex 2s |
| Biocircuit Technologies INC | $35.71 | 2025 | Nerve Tape |
| Kci USA, INC. | $27.08 | 2023 | V.A.C. Dermatac, Prevena, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Willson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.